Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Alphabet (Google) Class A
GOOGL
|
$383M |
| 2 |
Costco
COST
|
$267M |
| 3 |
Pfizer
PFE
|
$231M |
| 4 |
Microsoft
MSFT
|
$230M |
| 5 |
Bristol-Myers Squibb
BMY
|
$227M |
Top Sells
| 1 |
CVS Health
CVS
|
$258M |
| 2 |
EMC
EMC CORPORATION
EMC
|
$228M |
| 3 |
GAS
AGL RESOURCES INC (HOLDING CO)
GAS
|
$216M |
| 4 |
Charter Communications
CHTR
|
$142M |
| 5 |
TE
TECO ENERGY INC
TE
|
$136M |
Sector Composition
| 1 | Technology | 15.67% |
| 2 | Healthcare | 12.42% |
| 3 | Financials | 11.99% |
| 4 | Consumer Staples | 9.63% |
| 5 | Industrials | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Idexx Laboratories
IDXX
$51.2B
| $78.3M | 0.14% |
694,304
+156,900
| +29% | +$17.7M |
|
152
Berkshire Hathaway Class A
BRK.A
$1.09T
| $78.1M | 0.14% |
361
+88
| +32% | +$19M |
|
153
Charles River Laboratories
CRL
$7.99B
| $78M | 0.14% |
935,909
+155,800
| +20% | +$13M |
|
154
Gen Digital
GEN
$18.2B
| $77.9M | 0.14% |
3,102,038
-400,141
| -11% | -$10M |
|
155
Toronto Dominion Bank
TD
$128B
| $77.8M | 0.14% |
1,752,300
+239,200
| +16% | +$10.6M |
|
|
PXD
156
DELISTED
Pioneer Natural Resource Co.
PXD
| $76.7M | 0.14% |
413,388
-14,005
| -3% | -$2.6M |
|
157
Pan American Silver
PAAS
$12.1B
| $76.2M | 0.13% |
4,323,817
-1,521,700
| -26% | -$26.8M |
|
158
Ultrapar
UGP
$3.88B
| $75.9M | 0.13% |
6,935,200
-1,425,400
| -17% | -$15.6M |
|
|
MZTI
159
The Marzetti Company Common Stock
MZTI
$5.06B
| $75.9M | 0.13% |
574,500
-35,000
| -6% | -$4.62M |
|
160
Booking.com
BKNG
$181B
| $75.6M | 0.13% |
+51,399
| New | +$75.6M |
|
161
AutoZone
AZO
$70.8B
| $75.6M | 0.13% |
98,400
+68,700
| +231% | +$52.8M |
|
|
NTRI
162
DELISTED
NutriSystem, Inc.
NTRI
| $75.2M | 0.13% |
2,532,500
+32,600
| +1% | +$968K |
|
163
British American Tobacco
BTI
$121B
| $74.7M | 0.13% |
1,171,000
+98,400
| +9% | +$6.28M |
|
164
Biogen
BIIB
$20.5B
| $74.6M | 0.13% |
238,261
+197,861
| +490% | +$61.9M |
|
|
DD
165
DELISTED
Du Pont De Nemours E I
DD
| $74.1M | 0.13% |
1,106,800
+701,400
| +173% | +$47M |
|
166
TSMC
TSM
$1.22T
| $74.1M | 0.13% |
2,422,451
-354,000
| -13% | -$10.8M |
|
167
Eli Lilly
LLY
$666B
| $74M | 0.13% |
922,200
-1,269,005
| -58% | -$102M |
|
168
Annaly Capital Management
NLY
$14B
| $73.8M | 0.13% |
1,757,527
-914,348
| -34% | -$38.4M |
|
169
Boeing
BA
$174B
| $73.2M | 0.13% |
555,300
+528,000
| +1,934% | +$69.6M |
|
170
Equinor
EQNR
$60.7B
| $72.6M | 0.13% |
4,321,600
-158,698
| -4% | -$2.67M |
|
|
AZPN
171
DELISTED
ASPEN TECHNOLOGY INC
AZPN
| $71.8M | 0.13% |
1,534,500
-41,300
| -3% | -$1.93M |
|
|
TFCFA
172
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
| $71.7M | 0.13% |
2,960,400
+778,400
| +36% | +$18.9M |
|
173
Post Holdings
POST
$5.86B
| $70.2M | 0.12% |
1,390,786
+237,146
| +21% | +$12M |
|
174
Telephone and Data Systems
TDS
$4.54B
| $70.1M | 0.12% |
2,578,792
+171,800
| +7% | +$4.67M |
|
|
TARO
175
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $69.6M | 0.12% |
629,900
+9,000
| +1% | +$995K |
|